Evidence map›Paper›PMID 38222033›Full record

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2024

Targeted Metabolomics Analysis of Serum Amino Acids in T2DM Patients.

Li Bao, Bowen Wu, Chunjing Yang, Xiqiao Xu, Zhengyuan Shi, Dechun Jiang

Open access · goldAbstract read
In one paragraph

Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Serum Lipidomic Analysis of T2DM Patients: A Potential Biomarker Study.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Article
  4. Article
  5. Multi Omics Applications in Biological Systems.Current issues in molecular biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Li BaoDepartment of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, People's Republic of China.
Bowen WuInstitute for TCM-X, MOE Key Laboratory of Bioinformatics, Bioinformatics Division, BNRIST, Department of Automation, Tsinghua University, Beijing, People's Republic of China.
Chunjing YangDepartment of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, People's Republic of China.
Xiqiao XuDepartment of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, People's Republic of China.
Zhengyuan ShiDepartment of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, People's Republic of China.
Dechun JiangDepartment of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, People's Republic of China.
Capital Medical University · CNBeijing Shijitan Hospital · CNTsinghua University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Amino acids are the important metabolites in the body and play a crucial role in biological processes. The purpose of this study is to provide a profile of amino acids change in the serum of T2DM patients and identify potential biomarkers. Patients and Methods: In this study, we quantitatively determined the serum amino acid profiles of 30 T2DM patients and 30 healthy volunteers. Results: Thirty-four amino acids were quantified, and 19 amino acid levels differed significantly between T2DM and Healthy groups. Screened by the specific screening criteria (VIP>1.0; P<0.05; FC>1.5, or FC<0.67) in MetaboAnalyst 5.0 platform, 8 amino acids were identified as potential biomarkers. Pearson rank correlation test showed 14 differential amino acids were significantly correlated with T2DM-related physiological parameters. Conclusion: The results of this study provide theoretical basis for the subsequent development of dietary supplements for the prevention or treatment of T2DM and its complications.

Indexed as

amino acidsbiomarkerdiabetes mellitus type 2T2DMtargeted metabolomics

Identifiers

PMID38222033
PMCPMC10788071
OpenAlexW4390697591

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.